Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 133865-89-1 | Product Number: S0935
Safinamide
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- (S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propionamide
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 100MG |
$426.00
|
1 | 1 | 3 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | S0935 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__7H__1__9FN__2O__2 = 302.35 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 133865-89-1 |
| Reaxys Registry Number | 7142233 |
| PubChem Substance ID | 253662371 |
| Merck Index (14) | 8315 |
| MDL Number | MFCD00897036 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 8.70 to 9.70 % |
| Specific rotation [a]20/D | +15.0 to +19.0 deg(C=1, AcOH(95vol%)) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 212 °C |
| Specific Rotation | 17° (C=1,95% CH3COOH) |
GHS
Related Laws:
| RTECS# | TX1457385 |
Transport Information:
| HS Number | 2924.29.7790 |
Application
Safinamide: A Na, K Channel Modulator and Monoamine Oxidase B (MAOB) Inhibitor
Safinamide is a sodium and calcium channel modulator, and also inhibits monoamine oxidase B (MAOB) which is an enzyme that catalyzes the oxidation of monoamines. Safinamide is used for the treatment of epilepsy and Parkinson's disease (PD). (The product is for research purpose only.)
References
- Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity
- Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs
- Safinamide (a review)
- Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions (a review)
- Safinamide in the treatment of Parkinson's disease (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.